Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRPO

Precipio Inc

Apr 17 • 04:00PM ET

28.30

-0.70 -2.41 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: HOLX BIO DGX LH NTRA NEO QGEN VERI CDNA FLGT

| Held by: VXF VTI DFSU DFAS DCOR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.29	Insider Own	8.23%	Shs Outstand	1.78M	Perf Week	3.85%
Market Cap	50.48M	Forward P/E	-	EPS next Y	-	Insider Trans	0.06%	Shs Float	1.64M	Perf Month	-0.91%
Enterprise Value	51.48M	PEG	-	EPS next Q	-	Inst Own	17.04%	Short Float	0.37%	Perf Quarter	17.92%
Income	-0.36M	P/S	2.10	EPS this Y	-	Inst Trans	-4.76%	Short Ratio	0.28	Perf Half Y	60.98%
Sales	24.05M	P/B	3.46	EPS next Y	-	ROA	-1.89%	Short Interest	0.01M	Perf YTD	23.15%
Book/sh	8.18	P/C	19.05	EPS next 5Y	-	ROE	-2.72%	52W High	29.80 -5.03%	Perf Year	381.29%
Cash/sh	1.49	P/FCF	140.23	EPS past 3/5Y	72.37% 57.83%	ROIC	-2.07%	52W Low	5.21 443.19%	Perf 3Y	102.75%
Dividend Est.	-	EV/EBITDA	93.60	Sales past 3/5Y	36.71% 31.60%	Gross Margin	37.23%	Volatility	4.81% 6.19%	Perf 5Y	-23.51%
Dividend TTM	-	EV/Sales	2.14	EPS Y/Y TTM	90.12%	Oper. Margin	-5.00%	ATR (14)	1.58	Perf 10Y	-99.50%
Dividend Ex-Date	-	Quick Ratio	1.36	Sales Y/Y TTM	29.77%	Profit Margin	-1.51%	RSI (14)	55.72	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.61	EPS Q/Q	220.87%	SMA20	4.62%	Beta	1.34	Target Price	19.00
Payout	-	Debt/Eq	0.25	Sales Q/Q	22.92%	SMA50	10.26%	Rel Volume	0.62	Prev Close	29.00
Employees	61	LT Debt/Eq	0.21	Earnings	Apr 02 AMC	SMA200	34.04%	Avg Volume	21.95K	Price	28.30
IPO	Jul 18, 2000	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	13,511	Change	-2.41%

Mar-31-26 08:30AM	Precipio, Inc. Q4 2025 Earnings Call Summary (Moby)
Mar-12-26 05:00PM	Precipio Announces Q4 and year-end 2025 Shareholder Update Call (GlobeNewswire) -6.66%
Mar-10-26 09:00AM	Precipio Announces Publication of a Joint Study with Memorial Sloan-Kettering Cancer Center Highlighting Its Cutting-Edge Bloodhound BCR::ABL1 Assay (GlobeNewswire)
Feb-25-26 09:30AM	Precipio 2025 (Unaudited) Revenues Grew to $24.0M, a 30% Increase Year-Over-Year (GlobeNewswire)
Jan-15-26 09:00AM	Precipio Takes Major Steps Toward a Clean Balance Sheet (GlobeNewswire)
01:53AM	Loading…
Dec-26-25 01:53AM	The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio (Zacks)
Dec-24-25 01:10PM	Top Stock Reports for AbbVie, Coca-Cola & Chevron (Zacks)
Dec-05-25 10:00AM	Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting (GlobeNewswire)
Dec-04-25 08:00AM	Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact (GlobeNewswire)
Nov-19-25 11:34AM	Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow (Zacks) +12.28%
Nov-18-25 12:01AM	Precipio Inc (PRPO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +11.17%
Nov-14-25 04:30PM	Precipio Announces its Q3-2025 Financial Results (GlobeNewswire) +8.79%
Nov-04-25 05:00PM	Precipio Announces Q3-2025 Shareholder Update Call (GlobeNewswire)
Sep-23-25 11:58AM	The Zacks Analyst Blog Highlights HSBC, American Express, TotalEnergies, Armanino Foods of Distinction and Precipio (Zacks)
Sep-22-25 04:10PM	Top Stock Reports for HSBC, American Express & TotalEnergies (Zacks)
10:00AM	Loading…
Sep-02-25 10:00AM	Precipio Terminates Its ATM (GlobeNewswire)
Aug-13-25 05:00PM	Precipio Announces its Q2-2025 Financial Results (GlobeNewswire)
Jul-31-25 04:30PM	Precipio Announces Q2-2025 Shareholder Update Call (GlobeNewswire)
Jul-11-25 04:30PM	Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless (GlobeNewswire)
Jul-08-25 12:02PM	Arena Group Holdings vs. Precipio: 2 New Top 100 Stocks to Buy. Precipios the Buy. (Barchart) +13.16%
Jul-07-25 06:03AM	The Zacks Analyst Blog Highlights Apple, Oracle, Goldman Sachs and Precipio (Zacks) +16.02%
Jul-03-25 04:25PM	Top Research Reports for Apple, Oracle & Goldman Sachs (Zacks) +6.67%
Jun-16-25 12:00PM	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
May-16-25 05:01PM	Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ... (GuruFocus.com) +10.21% +6.22%
May-14-25 05:00PM	Precipio Announces its Q1-2025 Financial Results (GlobeNewswire)
May-01-25 05:00PM	Precipio Announces Q1-2025 Shareholder Update Call (GlobeNewswire) +15.26%
Apr-22-25 08:59AM	The Zacks Analyst Blog Highlights Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio (Zacks)
Apr-21-25 04:49PM	Top Research Reports for Visa, ServiceNow & Progressive (Zacks) -10.88%
Apr-02-25 09:00AM	Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ... (GuruFocus.com)
Mar-31-25 10:50PM	Precipio, Inc. (PRPO) Q4 2024 Earnings Call Transcript (Seeking Alpha)
05:00PM	Loading…
Mar-17-25 05:00PM	Precipio Announces Q4 and year-end 2024 Shareholder Update Call (GlobeNewswire) +9.22% -8.06%
Feb-26-25 09:45AM	Precipio achieves positive adjusted EBITDA, cash flow in Q4 (TipRanks) -13.54%
Feb-25-25 09:30AM	Precipio Achieves Key Q4-2024 Financial Goals: Positive Adjusted EBITDA and Positive Cash Flow (unaudited) (GlobeNewswire) -12.69%
Jan-16-25 05:00PM	Precipio grants senior management performance-based awards instead of traditional time-vested ESOPs (GlobeNewswire) +5.85%
Nov-20-24 08:00AM	Precipio Inc (PRPO) Q3 2024 Earnings Call Highlights: Strong Growth in Diagnostic Services and ... (GuruFocus.com)
Nov-06-24 05:00PM	Precipio Announces Q3-2024 Shareholder Update Call (GlobeNewswire)
Oct-08-24 10:00AM	Precipio Expands Bloodhound MPN Panel by Adding CALR Mutation Subtyping (GlobeNewswire)
Sep-06-24 04:00PM	Precipio Announces Employee Stock Option Plan Repricing (GlobeNewswire)
Aug-15-24 05:00PM	Precipio Announces Q2-2024 Shareholder Update Call (GlobeNewswire) +5.96%
Jul-25-24 09:00AM	Precipio Reports $0.3M cash generated by operations (unaudited) in Q2-2024, as the company advances towards breakeven (GlobeNewswire) +8.01%
Jul-17-24 09:00AM	Precipio Reports $4.4M for Q2-2024 (unaudited) Revenues, a leap of 30% from Q1-2024 (GlobeNewswire) +23.87%
Jun-13-24 04:00PM	Precipio Inc. Announces Adjournment of Annual Meeting of Stockholders (GlobeNewswire)
Jun-12-24 04:00PM	Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting (GlobeNewswire)
09:00AM	Precipio Provides Status Update on Current Business Matters (GlobeNewswire)
May-15-24 08:52AM	PRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
May-06-24 05:00PM	Precipio Secures a short-term $500K Credit Facility (GlobeNewswire)
Apr-01-24 10:53AM	PRPO Stock Earnings: Precipio Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Mar-25-24 05:00PM	Precipio Announces Year end 2023 Shareholder Update Call (GlobeNewswire)
Feb-13-24 10:00AM	Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY (GlobeNewswire)
Feb-06-24 10:00AM	Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer (GlobeNewswire) +8.24%
Jan-23-24 10:00AM	Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter (GlobeNewswire)
Jan-17-24 10:30AM	Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japan (GlobeNewswire) +15.37%
Jan-02-24 09:00AM	Precipio Announces Christina Valauri joins the Board of Directors (GlobeNewswire)
Dec-14-23 04:30PM	Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 (GlobeNewswire) +12.40%
Nov-16-23 05:00PM	Precipio Announces Q3-2023 Shareholder Update Call (GlobeNewswire) -7.74%
Oct-18-23 09:00AM	Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022 (GlobeNewswire)
Oct-03-23 10:00AM	Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023 (GlobeNewswire)
Sep-28-23 09:00AM	Precipio Continues to Sign New HemeScreen Customers (GlobeNewswire)
Sep-25-23 11:00AM	Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven (GlobeNewswire)
Sep-21-23 09:00AM	Precipio Takes Final Step Towards Regaining Nasdaq Compliance (GlobeNewswire) -10.41%
Sep-13-23 09:30AM	Precipios Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan (GlobeNewswire) +7.80%
Aug-31-23 03:26PM	11 ChatGPT Penny Stock Picks (Insider Monkey)
Aug-19-23 06:01AM	Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-13-23 10:16AM	Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story (Simply Wall St.)
Aug-10-23 05:00PM	Precipio Announces Q2-2023 Shareholder Update Call (GlobeNewswire)
Aug-08-23 09:00AM	Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel (GlobeNewswire)
Aug-03-23 09:00AM	Precipios Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven (GlobeNewswire)
Aug-01-23 09:00AM	Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023 (GlobeNewswire) +5.74%
Jun-14-23 09:49AM	Precipios Omnia Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy (GlobeNewswire)
Jun-13-23 09:00AM	Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology (GlobeNewswire)
Jun-08-23 08:30AM	Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement (GlobeNewswire) -29.40%
Jun-07-23 09:30AM	Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects (GlobeNewswire) +15.23%
May-22-23 11:00AM	Precipios Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology (GlobeNewswire)
May-17-23 04:00PM	Precipio Shares Growth Catalysts For HemeScreen (GlobeNewswire)
May-15-23 04:00PM	Precipio Announces Q1-2023 Shareholder Update Call (GlobeNewswire)
May-04-23 01:00PM	Precipio Adds Substantial Pathology Customer to its Diagnostic Services Division (GlobeNewswire) -6.71%
10:00AM	Precipio Signs Another HemeScreen Customer (GlobeNewswire)
Apr-27-23 05:00PM	Precipio Granted 180-day Extension From NASDAQ To Regain Compliance (GlobeNewswire)
Apr-19-23 11:00AM	Precipio Unaudited Q1-2023 Product Revenues Exceed The Two Prior Quarters (Q3+Q4 of 2022) Combined (GlobeNewswire)
Apr-09-23 10:25AM	Precipio, Inc. (NASDAQ:PRPO) Q4 2022 Earnings Call Transcript (Insider Monkey)
Apr-02-23 08:55AM	Precipio Full Year 2022 Earnings: US$0.54 loss per share (vs US$0.40 loss in FY 2021) (Simply Wall St.)
Mar-28-23 05:00PM	Precipio Announces 2022 Fourth Quarter and Year-End Shareholder Update Call (GlobeNewswire)
Mar-21-23 10:30AM	Precipio Ships First IV-Cell® Order to Major US Healthcare System (GlobeNewswire)
Mar-07-23 12:49PM	CORRECTION -- Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
12:00PM	Precipio continues to sign up and onboard HemeScreen customers (GlobeNewswire)
Feb-14-23 11:44AM	ThermoFisher Salesforce Votes Precipios HemeScreen® as Best New Product (GlobeNewswire)
Jan-11-23 10:00AM	Precipio Signs Another Major HemeScreen Customer (GlobeNewswire) +7.21%
Dec-06-22 10:00AM	Precipio Signs Additional Major HemeScreen Customer (GlobeNewswire)
Nov-07-22 10:30AM	Precipio Presents Poster on HemeScreen® Study at Association of Molecular Pathology (AMP) 2022 Annual Conference (GlobeNewswire)
Nov-02-22 05:00PM	Precipio Announces Third Quarter Shareholder Update Call (GlobeNewswire)
Oct-18-22 09:07AM	Precipio, Inc. (NASDAQ:PRPO) Is Expected To Breakeven In The Near Future (Simply Wall St.)
Sep-15-22 11:00AM	Precipio Signs Agreement with Another Major US Healthcare Distributor for HemeScreen (GlobeNewswire) +8.33%
Aug-24-22 11:00AM	Sharon Robins Joins Precipios Products Division as Senior Director of Laboratory & Hospital Sales (GlobeNewswire)
Aug-16-22 11:00AM	Precipio Launches New 1-Step Technology for all HemeScreen Assays (GlobeNewswire) -10.67%
Aug-10-22 10:00AM	Toni-Ann Mills Joins Precipios Products Division to Lead Channel Partner Training, Learning & Development (GlobeNewswire)
Aug-08-22 10:00AM	Precipio Announces Second Quarter Shareholder Update Call (GlobeNewswire)
Jul-20-22 10:30AM	Precipio to distribute HemeScreen® through Fisher Healthcare channel (GlobeNewswire)
Jun-14-22 02:00PM	Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote (GlobeNewswire)
Jun-13-22 11:00AM	Keith Meadors Joins Precipio to Lead its Products Division (GlobeNewswire) -9.40%
May-24-22 10:30AM	Precipio Receives CE-IVD Certification to Market Multiple HemeScreen® Panels in Europe (GlobeNewswire)

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. It operates through the following business divisions: Pathology Services and Products. The Pathology Services division provides specialized cancer diagnostic testing services to physicians, hospitals, and laboratories. The Products divisions develops and commercializes proprietary assays designed for use by clinical laboratories. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sabet Ahmed Zaki	Chief Operating Officer	Apr 01 '26	Buy	27.93	19	531	1,034	Apr 10 04:00 PM
Sabet Ahmed Zaki	Chief Operating Officer	Jan 02 '26	Buy	23.40	20	468	735	Jan 06 04:34 PM
Sabet Ahmed Zaki	Chief Operating Officer	Oct 01 '25	Buy	19.50	25	488	715	Nov 20 07:03 PM
Sabet Ahmed Zaki	Chief Operating Officer	Jul 08 '25	Buy	16.30	31	505	690	Nov 20 07:01 PM
LAPORTE KATHLEEN	Director	Sep 08 '25	Sale	20.06	6,152	123,409	6,151	Sep 10 04:03 PM
THE KATHLEEN D LAPORTE REVOCAB	Director	Sep 08 '25	Proposed Sale	20.06	6,152	123,385		Sep 09 04:16 PM
SANDBERG RICHARD A	Director	May 30 '25	Buy	10.00	1,399	13,986	40,175	May 30 04:31 PM
SANDBERG RICHARD A	Director	May 27 '25	Buy	9.80	101	990	38,776	May 28 04:37 PM
SANDBERG RICHARD A	Director	May 22 '25	Buy	9.33	500	4,665	38,675	May 27 04:05 PM
SANDBERG RICHARD A	Director	May 21 '25	Buy	9.27	8,035	74,474	38,175	May 22 05:01 PM
SANDBERG RICHARD A	Director	May 20 '25	Buy	8.47	4,251	36,006	30,140	May 21 04:34 PM
SANDBERG RICHARD A	Director	May 19 '25	Buy	8.21	714	5,862	25,889	May 21 04:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRPO

Precipio Inc

Upgrade your Finviz experience